Sellas Life Sciences Group Inc (SLS) Financials

$11.66

$0.37 (3.28%)

As on 16-Sep-2026 16:26EDT

Market cap

$2,331 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

16.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	1.00	7.60
Cost of Revenue	--	--	--	--	0.10	0.20
Gross Profit	--	--	--	--	0.90	7.40
Operating Expenses	35.22	28.27	31.51	37.87	42.85	32.69
Operating Profit (EBIT)	-35.22	-28.27	-31.51	-37.87	-41.95	-25.29
Other Income	--	--	--	--	--	--
Profit before Tax	-32.46	-26.86	-30.88	-37.34	-41.30	-20.94
Provision for Tax	--	--	--	-37.87	-0.65	-0.24
Profit after Tax (Net Income)	-32.46	-26.86	-30.88	-37.34	-41.30	-20.70
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	-41.30	-20.70

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	137.66	70.87	9.47	-7.98	4.85	20.35
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	0.16	0.46	0.46	0.46	0.58	1.10
Current Liabilities	7.57	7.02	9.51	13.74	15.52	4.98
Total Liabilities	152.95	78.35	19.43	6.22	20.94	26.43

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	2.88	3.13	3.31	3.05	3.19	3.38
Current Assets	142.51	75.21	16.33	3.17	17.76	23.04
Total Assets	152.95	78.35	19.43	6.22	20.94	26.43
Total Debt*	0.74	1.00	1.00	0.91	0.95	0.81
Net Current Assets	134.94	68.19	6.82	-10.56	2.24	18.06

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-28.39	-35.40	-31.41	-23.81	-26.02
Cash Flow from Investing Activities	--	--	--	-5.50	-4.50	-4.50
Cash from Financing Activities	--	86.30	46.76	22.32	24.08	12.07
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-0.21	-0.18	-0.42	-1.21	-1.99	-1.30
Cash EPS ($)	--	-0.18	-0.42	-1.21	-1.99	-1.30
Adjusted Book Value ($)	--	0.46	0.13	--	0.23	1.28
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-0.19	-0.48	-1.02	-1.15	-1.64
Free Cash Flow per Share ($)	--	-0.19	-0.48	-1.20	-1.36	-1.64

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-65.25	-1,818.67	5,861.85	-306.49	-82.62
ROE (%)	-31.13	-66.88	-4,147.88	2,389.76	-327.81	-85.70
ROA (%)	-33.95	-54.95	-240.78	-274.94	-174.38	-57.12
EBIT Margin (%)	--	--	--	--	-3,195.00	-257.82
Net Margin (%)	--	--	--	--	-4,130.10	-272.36
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	-1.00	-0.87	3,999.00
EBIT Growth (%)	74.85	--	17.30	-16.87	-63.06	-16.93
Net Profit Growth (%)	-23.62	13.01	17.30	9.59	-99.53	-23.52
EPS Growth (%)	35.39	0.58	0.66	0.39	-0.53	0.19
Book Value Growth (%)	174.25	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-21.49	-2.49	-0.87	-1.19	-4.25
Price / Book Value	16.94	8.14	8.13	-4.09	10.11	4.32
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-1.71	-18.85	101.36	58.47	-1.04	-3.67
Close Price ($)	14.76	3.77	1.04	1.06	2.36	5.53
High Price ($)	15.88	3.99	1.72	4.13	7.40	15.08
Low Price ($)	1.39	0.85	0.50	0.81	1.77	5.20
Market Cap ($ Cr)	2,331.46	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.11	-0.11	0.19	0.04
Short term debt to equity ratio	0.00	0.01	0.06	-0.06	0.08	0.01
Current Ratio	18.83	10.72	1.72	0.23	1.14	4.63
Quick Ratio	18.83	--	--	--	--	--
Interest Coverage	--	--	--	--	-49.23	-4.50

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	0.04	0.21
Receivable days	--	--	--	--	--	54.21
Inventory Days	--	--	--	--	--	849.21
Payable days	--	--	--	--	10,046.20	6,210.16
Cash Conversion Cycle	--	--	--	--	--	-5,306.75

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.